ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 629730 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 629730; 2) Community: the network communities that were significantly associated with the response to NSC 629730; 3) Molecule: the relationships between components within communities and NSC 629730; 4) MDR: the compounds that were significantly associated with the NSC 629730.

NSC Compound Enrichment Correlation
NSC 225112 2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- 0.0160549908501539 0.47357762
NSC 286193 Tiazofurin (USAN) 0.0160549908501539 0.23002759
NSC 3082 s-Triazine, 4,6-diamino-1-(m-bromophenyl)-1,2-dihydro-2,2-dimethyl-, hydrochloride (8CI) 0.0160549908501539 0.3832584
NSC 366739 CHAETOGLOBOSIN A 0.0160549908501539 -0.0030269598
NSC 373355 Saframycin R 0.0160549908501539 0.17601496
NSC 403572 Acetophenone, 4'-bromo-2-hydroxy-, benzoate (8CI) 0.0160549908501539 0.22660189
NSC 44585 9H-Purin-2-amine, 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9-(2-methylpropyl)- (9CI) 0.0160549908501539 -0.07666589
NSC 529108 4-Fluoro-D,L-tryptophan 0.0160549908501539 0.3193894
NSC 58905 9H-Purine, 9-(2-chloroethyl)-6-[(phenylmethyl)thio]- (9CI) 0.0160549908501539 0.45379776
NSC 610456 Camptothecin Derivative 0.0160549908501539 0.22042504
Total:128  Current:41    [First] [Prev] [Next] [Last]